Application 090513

Type
ANDA
Sponsor
AUROBINDO PHARMA LTD

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEEMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATETABLET;ORAL200MG;300MGNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
65862-354Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil FumarateAurobindo Pharma LimitedANDACurrent
65862-354Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil FumarateAurobindo Pharma LimitedANDACurrent
65862-354Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil FumarateAurobindo Pharma LimitedANDACurrent
70518-3077Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil FumarateREMEDYREPACK INC.ANDACurrent
70518-3077Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil FumarateREMEDYREPACK INC.ANDACurrent
70518-3077Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil FumarateREMEDYREPACK INC.ANDACurrent
71335-1844Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil FumarateBryant Ranch PrepackANDACurrent
72189-403TruvadaEmtricitabine/TDFDirect_RxANDACurrent

Documents

DocumentSubmission typeDate
52553ORIG2018-02-09
9271ORIG2009-04-03